SILENT-SEEDS
Seed bank Silent Seeds and famous breeder Mario Guzman, founder of Sherbinskis, are proud to announce their partnership in a range of five unique US exotic varieties.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221214005114/en/
(Photo: Silent Seeds)
Following an initial highly successful collaboration with the rapper Booba and the creation of his own seed strain (B-45), the Silent Seeds teams are proud to be embarking on a significant new strategic partnership with Mario Guzman, one of the best breeders of his generation.
Creator of the brand C, his work is recognized and appreciated worldwide. He is particularly well known for developing two of the most iconic strains in the cannabis world: Gelato and the Gelato lineage of Bacio, Acaiberry, Mochi and Gello, and the famous Sunset Sherbert.
The collaboration between Silent Seeds and Sherbinskis will offer a range of five unique US exotic varieties, of which 3 are feminized (Polar Gelato, Pink Sunset, and Acai Jelly) and 2 are autoflowering (Polar Gelato Auto and Pink Sunset Auto). They are available at www.silent-seeds.com.
Strongly inspired by the US spirit and Californian vibes, this collection signals the initial stage in marrying together knowledge that is recognized as the best in the world and the will to achieve genetic excellence.
"We are very excited about our partnership with Mario Guzman, confirming the return of Silent Seeds as a leader in the field. This is due to the work by all the teams, boasting experience of more than 20 years, and our strategic action plan since we took over Dinafem's historic genetics bank." - Alexandre-Henri Lacarré, CEO of Silent Seeds
The collaboration also signals the transatlantic ambitions of Silent Seeds, with the launch of a growth project to be completed by the end of 2023.
The teams from Silent Seeds and Sherbinskis will be delighted to meet you at the next edition of Spannabis, March 10 to March 12, 2023, Europe's leading international Cannabis Fair. Stand 129, Hall 1. Over two days, at the conference and in meetings, Mario Guzman will be sharing his vision and experience with all attendees.
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221214005114/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OpZira, Inc. Launches to Advance Ophthalmic Diagnostics with Innovative Medical Device Portfolio3.9.2025 19:23:00 CEST | Press release
OpZira™, Inc., a forward-thinking ophthalmic medical device company founded on a legacy of research excellence, today announced its official formation. OpZira is dedicated to delivering innovative technologies that enhance the detection and monitoring of ocular disease, empowering clinicians with advanced diagnostic tools. OpZira’s creation follows Alcon’s acquisition of LumiThera (https://www.alcon.com/media-release/alcon-completes-acquisition-lumithera/) and its innovative Valeda® Light Delivery System, the first and only FDA-authorized treatment for dry age-related macular degeneration (AMD). As part of the transaction, LumiThera’s diagnostic product lines were spun off to LumiThera shareholders, leading to the establishment of OpZira, Inc. OpZira’s product portfolio includes: AdaptDx Pro® – A wearable dark adaptometer that leverages AI to ensure a consistent patient experience. Impaired dark adaptation speed, a key early indicator of rod-mediated dysfunction, is often among the fir
BTG Bioliquids and NanosTech Partner to Deliver End-to-End Advanced Biofuels Solution3.9.2025 18:19:00 CEST | Press release
BTG Bioliquids BV (BTL), a Netherlands-based leader in fast pyrolysis technology, and NanosTech Technology & Innovations Ltd. (NanosTech), a Canada-based catalyst development and manufacturing company, have signed a Memorandum of Understanding (MOU) to deliver a fully integrated solution to produce advanced, drop-in biofuels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903698730/en/ The partnership combines BTL’s proven fast pyrolysis technology, which converts sustainable biomass into bio-oil, with NanosTech’s proprietary Aquaprocessing (AQP) platform, which upgrades even the most challenging bio-oils into refinery-ready feedstocks to produce fuels such as sustainable aviation fuel (SAF), renewable diesel, and marine fuels. The two companies are now actively collaborating to determine the location in Canada and Europe for the new 500-barrel-per-day modular biorefinery system. This system can be deployed near the feeds
Armis Named a Leader in IoT Security Solutions, Q3 2025 Evaluation3.9.2025 15:58:00 CEST | Press release
Recognition follows Armis being named a Leader in Unified Vulnerability Management Solutions evaluation Armis, the cyber exposure management & security company, today announced that it has been named a Leader in The Forrester Wave™: IoT Security Solutions, Q3 2025. This achievement comes on the heels of Armis being named a Leader in The Forrester Wave™: Unified Vulnerability Management Solutions, Q3 2025. In this Forrester Wave™, Armis is ranked a Leader and achieved the highest scores possible in 9 key criteria. According to the report, “Armis’ vision centers on delivering enterprise-wide exposure management that goes beyond IoT and OT devices. Its innovation investments and acquisitions support this goal. Its roadmap aligns with customer priorities while anticipating future needs to ensure the platform evolves alongside its clients. This forward-looking strategy fosters successful adoption and helps customers deploy the Centrix platform successfully.” “We’re proud to once again be re
Rapid Medical™ Surpasses 1,000 Cases With DRIVEWIRE™ 24 in North America and Expands Into Europe With MDR Approval3.9.2025 15:46:00 CEST | Press release
Clinical performance and strong physician demand drive swift uptake and global approval of next-generation access technology Rapid Medical™, a leading developer of active endovascular devices, announces that its DRIVEWIRE™ 24 steerable guidewire has been used in more than 1,000 neurovascular procedures in North America during a limited commercial launch beginning earlier this year. The company also announced receipt of CE Mark under the European Medical Device Regulation (MDR), as presented at the 2025 ESMINT Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903530140/en/ “In my experience, the wire provides a unique combination of precision and support that simply hasn’t been possible with conventional technologies,” stated Dr. Erez Nossek, a neurosurgeon at NYU Langone in New York, NY. “It has become a reliable tool that allows us to approach any anatomy with greater efficiency and less time.” As the first
Ondo Finance and Alpaca Collaborate to Tokenize US Stocks and ETFs3.9.2025 15:30:00 CEST | Press release
Bridging traditional finance and on-chain markets, increasing access to high-quality assets Today, Ondo Finance, a leader in blockchain-based financial innovation and tokenized real-world assets, announced the launch of Ondo Global Markets, their platform for tokenized US stocks and ETFs. The platform is powered by a strategic integration with Alpaca, a self-clearing broker-dealer and brokerage infrastructure API for stocks, ETFs, and options trading, as well as crypto. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903244835/en/ Ondo Finance and Alpaca collaborate to tokenize US stocks and ETFs; bridging traditional finance and on-chain markets, increasing access to high-quality assets. According to a McKinsey report, the tokenized market capitalization could reach around $2 trillion by 2030 across a variety of asset classes. This expected rise in market demand for tokenized assets, like US stocks and ETFs, comes as glob
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom